Skip to main content
SpringerLink
Log in

Treatment of Seizures

  • Chapter
  • First Online:
Absolute Epilepsy and EEG Rotation Review

  • 2042 Accesses

Abstract

Early and appropriate treatment of seizures is important for optimum seizure control and to avoid the consequences of continued seizure activity. With more than 20 antiepileptic drugs (AEDs) now available, choosing the best medication(s) for each patient can be challenging. Appropriate medication selection begins with an understanding of the various mechanisms of action, pharmacokinetics, side effect profile, and treatment of other comorbidities. Nevertheless, despite treatment with proper AEDs, up to 40% of patients will have drug resistant epilepsy (DRE). The importance of DRE must be emphasized as it may lead to developmental delay in children, hinder the development of interpersonal and vocational skills, cause psychological distress, memory problems, and is associated with an increased mortality rate. Early identification of DRE and timely referral to an epilepsy center for surgical evaluation is essential to allow for the greatest chance of improvement. Several options for the treatment of DRE are available and include diet therapy, standard resection, stimulation devices, and other procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abou-Khalil BW. Antiepileptic drugs. Continuum: Lifelong Learn Neurol. 2016;22(1, Epilepsy):132–56.

    Google Scholar 

  2. Hauser WA, Rich SS, Annegers JF, et al. Seizure recurrence after a 1st unprovoked seizure: an extended follow-up. Neurology. 1990;40(8):1163–70.

    Article  CAS  PubMed  Google Scholar 

  3. Khaleghi F, Nemec EC. Brivaracetam (briviact): a novel adjunctive therapy for partial-onset seizures. Pharm Ther. 2017;42(2):92–6.

    Google Scholar 

  4. Zupanc ML, Roell Werner R, Schwabe MS, et al. Efficacy of felbamate in the treatment of intractable pediatric epilepsy. Pediatr Neurol. 2010;42(6):396–403.

    Article  PubMed  Google Scholar 

  5. Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs II: treatment resistant epilepsy: report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018;91(2):82–90.

    Article  CAS  PubMed  Google Scholar 

  6. Poolos NP, Warner LN, Humphreys SZ, et al. Comparative efficacy of combination drug therapy in refractory epilepsy. Neurology. 2012;78(1):62–8.

    Article  CAS  PubMed  Google Scholar 

  7. Neligan A, Shorvon SD. Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review. Arch Neurol. 2010;67(8):931–40.

    Article  PubMed  Google Scholar 

  8. Lowenstein DH, Bleck T, Macdonald RL. It’s time to revise the definition of status epilepticus. Epilepsia. 1999;40(1):120–2.

    Article  CAS  PubMed  Google Scholar 

  9. Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus–report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10):1515–23.

    Article  PubMed  Google Scholar 

  10. Ferlisi M, Shorvon S. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain. 2012;135.(Pt 8:2314–28.

    Article  PubMed  Google Scholar 

  11. Young GB, Doig GS. Continuous EEG monitoring in comatose intensive care patients: epileptiform activity in etiologically distinct groups. Neurocrit Care. 2005;2(1):5–10.

    Article  PubMed  Google Scholar 

  12. Claassen J, Mayer SA, Kowalski RG, et al. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62(10):1743–8.

    Article  CAS  PubMed  Google Scholar 

  13. Towne AR, Waterhouse EJ, Boggs JG, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology. 2000;54(2):340–5.

    Article  CAS  PubMed  Google Scholar 

  14. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia. 1998;39(8):833–40.

    Article  CAS  PubMed  Google Scholar 

  15. Leitinger M, Trinka E, Gardella E, et al. Diagnostic accuracy of the Salzburg EEG criteria for non-convulsive status epilepticus: a retrospective study. Lancet Neurol. 2016;15(10):1054–62.

    Article  PubMed  Google Scholar 

  16. Beniczky S, Hirsch LJ, Kaplan PW, et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia. 2013;54(Suppl 6):28–9.

    Article  PubMed  Google Scholar 

  17. Leitinger M, Beniczky S, Rohracher A, et al. Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus–approach to clinical application. Epilepsy Behav. 2015;49:158–63.

    Article  CAS  PubMed  Google Scholar 

  18. Walker MC. Treatment of nonconvulsive status epilepticus. Int Rev Neurobiol. 2007;81:287–97.

    Article  PubMed  Google Scholar 

  19. Drislane FW. Evidence against permanent neurologic damage from nonconvulsive status epilepticus. J Clin Neurophysiol. 1999;16(4):323–31. discussion 353

    Article  CAS  PubMed  Google Scholar 

  20. Meierkord H, Holtkamp M. Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol. 2007;6(4):329–39.

    Article  PubMed  Google Scholar 

  21. Holtkamp M, Meierkord H. Nonconvulsive status epilepticus: a diagnostic and therapeutic challenge in the intensive care setting. Ther Adv Neurol Disord. 2011;4(3):169–81.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Jagoda A, Riggio S. Refractory status epilepticus in adults. Ann Emerg Med. 1993;22(8):1337–48.

    Article  CAS  PubMed  Google Scholar 

  23. Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48–61.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Fang Y, Wang X. Ketamine for the treatment of refractory status epilepticus. Seizure. 2015;30:14–20.

    Article  PubMed  Google Scholar 

  25. Neligan A, Shorvon SD. Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: a review. Epilepsy Res. 2011;93(1):1–10.

    Article  CAS  PubMed  Google Scholar 

  26. Leitinger M, Holler Y, Kalss G, et al. Epidemiology-based mortality score in status epilepticus (EMSE). Neurocrit Care. 2015;22(2):273–82.

    Article  CAS  PubMed  Google Scholar 

  27. Giovannini G, Monti G, Tondelli M, et al. Mortality, morbidity and refractoriness prediction in status epilepticus: comparison of STESS and EMSE scores. Seizure. 2017;46:31–7.

    Article  PubMed  Google Scholar 

  28. Shields WD. Infantile spasms: little seizures, BIG consequences. Epilepsy Curr. 2006;6(3):63–9.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Gibbs EL, Fleming MM, Gibbs FA. Diagnosis and prognosis of hypsarrhythmia and infantile spasms. Pediatrics. 1954;13(1):66–73.

    Google Scholar 

  30. Hrachovy RA, Frost JD Jr, Kellaway P. Hypsarrhythmia: variations on the theme. Epilepsia. 1984;25(3):317–25.

    Article  CAS  PubMed  Google Scholar 

  31. Go CY, Mackay MT, Weiss SK, et al. Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2012;78(24):1974–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Mackay MT, Weiss SK, Adams-Webber T, et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology. 2004;62(10):1668–81.

    Article  CAS  PubMed  Google Scholar 

  33. Arzimanoglou A, French J, Blume WT, et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol. 2009;8(1):82–93.

    Article  PubMed  Google Scholar 

  34. Thiele EA, Marsh ED, French JA, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018;391(10125):1085–96.

    Article  CAS  PubMed  Google Scholar 

  35. Gallentine WB, Mikati MA. Genetic generalized epilepsies. J Clin Neurophysiol. 2012;29(5):408–19.

    Article  PubMed  Google Scholar 

  36. Glauser TA, Cnaan A, Shinnar S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med. 2010;362(9):790–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Glauser TA, Cnaan A, Shinnar S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia. 2013;54(1):141–55.

    Article  CAS  PubMed  Google Scholar 

  38. Mattson RH. Overview: idiopathic generalized epilepsies. Epilepsia. 2003;44(Suppl 2):2–6.

    Article  PubMed  Google Scholar 

  39. Ferrie CD. Idiopathic generalized epilepsies imitating focal epilepsies. Epilepsia. 2005;46(Suppl 9):91–5.

    Article  PubMed  Google Scholar 

  40. Mantoan L, Walker M. Treatment options in juvenile myoclonic epilepsy. Curr Treat Options Neurol. 2011;13(4):355–70.

    Article  PubMed  Google Scholar 

  41. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369(9566):1016–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Calleja S, Salas-Puig J, Ribacoba R, et al. Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate. Seizure. 2001;10(6):424–7.

    Article  CAS  PubMed  Google Scholar 

  43. Nicolson A, Appleton RE, Chadwick DW, et al. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatry. 2004;75(1):75–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Baykan B, Martinez-Juarez IE, Altindag EA, et al. Lifetime prognosis of juvenile myoclonic epilepsy. Epilepsy Behav. 2013;28(Suppl 1):S18–24.

    Article  PubMed  Google Scholar 

  45. Knupp KG, Wirrell EC. Treatment strategies for Dravet syndrome. CNS Drugs. 2018;32(4):335–50.

    Article  CAS  PubMed  Google Scholar 

  46. Dilena R, Striano P, Gennaro E, et al. Efficacy of sodium channel blockers in SCN2A early infantile epileptic encephalopathy. Brain and Development. 2017;39(4):345–8.

    Article  PubMed  Google Scholar 

  47. Thompson EM, Wozniak SE, Roberts CM, et al. Vagus nerve stimulation for partial and generalized epilepsy from infancy to adolescence. J Neurosurg Pediatr. 2012;10(3):200–5.

    Article  PubMed  Google Scholar 

  48. Ng M, Devinsky O. Vagus nerve stimulation for refractory idiopathic generalised epilepsy. Seizure. 2004;13(3):176–8.

    Article  PubMed  Google Scholar 

  49. Morris GL 3rd, Gloss D, Buchhalter J, et al. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013;81(16):1453–9.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Vonck K, Van Laere K, Dedeurwaerdere S, et al. The mechanism of action of vagus nerve stimulation for refractory epilepsy: the current status. J Clin Neurophysiol. 2001;18(5):394–401.

    Article  CAS  PubMed  Google Scholar 

  51. Spanaki MV, Allen LS, Mueller WM, et al. Vagus nerve stimulation therapy: 5-year or greater outcome at a university-based epilepsy center. Seizure. 2004;13(8):587–90.

    Article  PubMed  Google Scholar 

  52. Ben-Menachem E, Hellstrom K, Waldton C, et al. Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years. Neurology. 1999;52(6):1265–7.

    Article  CAS  PubMed  Google Scholar 

  53. Elliott RE, Morsi A, Tanweer O, et al. Efficacy of vagus nerve stimulation over time: review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS > 10 years. Epilepsy Behav. 2011;20(3):478–83.

    Article  PubMed  Google Scholar 

  54. Helmers SL, Begnaud J, Cowley A, et al. Application of a computational model of vagus nerve stimulation. Acta Neurol Scand. 2012;126(5):336–43.

    Article  CAS  PubMed  Google Scholar 

  55. Heck C, Helmers SL, DeGiorgio CM. Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use. Neurology. 2002;59(6 Suppl 4):S31–7.

    Article  CAS  PubMed  Google Scholar 

  56. Eggleston KS, Olin BD, Fisher RS. Ictal tachycardia: the head-heart connection. Seizure. 2014;23(7):496–505.

    Article  PubMed  Google Scholar 

  57. Geller EB, Skarpaas TL, Gross RE, et al. Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy. Epilepsia. 2017;58(6):994–1004.

    Article  PubMed  Google Scholar 

  58. Jobst BC, Kapur R, Barkley GL, et al. Brain-responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas. Epilepsia. 2017;58(6):1005–14.

    Article  PubMed  Google Scholar 

  59. Heck CN, King-Stephens D, Massey AD, et al. Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS System Pivotal trial. Epilepsia. 2014;55(3):432–41.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Bergey GK, Morrell MJ, Mizrahi EM, et al. Long-term treatment with responsive brain stimulation in adults with refractory partial seizures. Neurology. 2015;84(8):810–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Morrell MJ. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology. 2011;77(13):1295–304.

    Article  PubMed  Google Scholar 

  62. Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51(5):899–908.

    Article  PubMed  Google Scholar 

  63. Salanova V, Witt T, Worth R, et al. Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. Neurology. 2015;84(10):1017–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Bergqvist AG, Schall JI, Gallagher PR, et al. Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia. 2005;46(11):1810–9.

    Article  CAS  PubMed  Google Scholar 

  65. Kossoff EH, Zupec-Kania BA, Amark PE, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2009;50(2):304–17.

    Article  PubMed  Google Scholar 

  66. Felton EA, Cervenka MC. Dietary therapy is the best option for refractory nonsurgical epilepsy. Epilepsia. 2015;56(9):1325–9.

    Article  PubMed  Google Scholar 

  67. Kossoff EH, Laux LC, Blackford R, et al. When do seizures usually improve with the ketogenic diet? Epilepsia. 2008;49(2):329–33.

    Article  PubMed  Google Scholar 

  68. Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7(6):500–6.

    Article  PubMed  Google Scholar 

  69. Payne NE, Cross JH, Sander JW, et al. The ketogenic and related diets in adolescents and adults–a review. Epilepsia. 2011;52(11):1941–8.

    Article  PubMed  Google Scholar 

  70. Morrison PF, Pyzik PL, Hamdy R, et al. The influence of concurrent anticonvulsants on the efficacy of the ketogenic diet. Epilepsia. 2009;50(8):1999–2001.

    Article  CAS  PubMed  Google Scholar 

  71. Hemingway C, Freeman JM, Pillas DJ, et al. The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics. 2001;108(4):898–905.

    Article  CAS  PubMed  Google Scholar 

  72. Vaccarezza MM, Silva WH. Dietary therapy is not the best option for refractory nonsurgical epilepsy. Epilepsia. 2015;56(9):1330–4.

    Article  PubMed  Google Scholar 

  73. Martinez CC, Pyzik PL, Kossoff EH. Discontinuing the ketogenic diet in seizure-free children: recurrence and risk factors. Epilepsia. 2007;48(1):187–90.

    Article  PubMed  Google Scholar 

  74. Kossoff EH, Cervenka MC, Henry BJ, et al. A decade of the modified Atkins diet (2003–2013): results, insights, and future directions. Epilepsy Behav. 2013;29(3):437–42.

    Article  PubMed  Google Scholar 

  75. Kossoff EH, Rowley H, Sinha SR, et al. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia. 2008;49(2):316–9.

    Article  CAS  PubMed  Google Scholar 

  76. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314–9.

    Article  CAS  PubMed  Google Scholar 

  77. Engel J Jr. What can we do for people with drug-resistant epilepsy? The 2016 Wartenberg Lecture. Neurology. 2016;87(23):2483–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069–77.

    Article  CAS  PubMed  Google Scholar 

  79. Berg AT, Langfitt J, Shinnar S, et al. How long does it take for partial epilepsy to become intractable? Neurology. 2003;60(2):186–90.

    Article  CAS  PubMed  Google Scholar 

  80. Fountain NB, Van Ness PC, Bennett A, et al. Quality improvement in neurology: epilepsy update quality measurement set. Neurology. 2015;84(14):1483–7.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Rosenow F, Lüders H. Presurgical evaluation of epilepsy. Brain. 2001;124(9):1683–700.

    Article  CAS  PubMed  Google Scholar 

  82. Smith D, Defalla BA, Chadwick DW. The misdiagnosis of epilepsy and the management of refractory epilepsy in a specialist clinic. QJM. 1999;92(1):15–23.

    Article  CAS  PubMed  Google Scholar 

  83. Alsaadi TM, Thieman C, Shatzel A, et al. Video-EEG telemetry can be a crucial tool for neurologists experienced in epilepsy when diagnosing seizure disorders. Seizure. 2004;13(1):32–4.

    Article  PubMed  Google Scholar 

  84. Loddenkemper T, Kotagal P. Lateralizing signs during seizures in focal epilepsy. Epilepsy Behav. 2005;7(1):1–17.

    Article  PubMed  Google Scholar 

  85. Dupont S, Semah F, Boon P, et al. Association of ipsilateral motor automatisms and contralateral dystonic posturing: a clinical feature differentiating medial from neocortical temporal lobe epilepsy. Arch Neurol. 1999;56(8):927–32.

    Article  CAS  PubMed  Google Scholar 

  86. Jayakar P, Gaillard WD, Tripathi M, et al. Diagnostic test utilization in evaluation for resective epilepsy surgery in children. Epilepsia. 2014;55(4):507–18.

    Article  PubMed  Google Scholar 

  87. Rheims S, Jung J, Ryvlin P. Combination of PET and magnetoencephalography in the presurgical assessment of MRI-negative epilepsy. Front Neurol. 2013;4:188.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Van Paesschen W. Ictal SPECT. Epilepsia. 2004;45(Suppl 4):35–40.

    Article  PubMed  Google Scholar 

  89. Lee GP, Park YD, Westerveld M, et al. Wada memory performance predicts seizure outcome after epilepsy surgery in children. Epilepsia. 2003;44(7):936–43.

    Article  PubMed  Google Scholar 

  90. Loring DW, Meador KJ, Lee GP, et al. Wada memory performance predicts seizure outcome following anterior temporal lobectomy. Neurology. 1994;44(12):2322–4.

    Article  CAS  PubMed  Google Scholar 

  91. Szaflarski JP, Gloss D, Binder JR, et al. Practice guideline summary: use of fMRI in the presurgical evaluation of patients with epilepsy: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2017;88(4):395–402.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Knowlton RC, Shih J. Magnetoencephalography in epilepsy. Epilepsia. 2004;45(Suppl 4):61–71.

    Article  PubMed  Google Scholar 

  93. Duncan JS. Imaging the Brain’s highways—diffusion tensor imaging in epilepsy. Epilepsy Curr. 2008;8(4):85–9.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Malmgren K, Olsson I, Engman E, et al. Seizure outcome after resective epilepsy surgery in patients with low IQ. Brain. 2008;131(Pt 2):535–42.

    Article  PubMed  Google Scholar 

  95. Glosser G, Salvucci AE, Chiaravalloti ND. Naming and recognizing famous faces in temporal lobe epilepsy. Neurology. 2003;61(1):81–6.

    Article  CAS  PubMed  Google Scholar 

  96. Dulay MF, Busch RM. Prediction of neuropsychological outcome after resection of temporal and extratemporal seizure foci. Neurosurg Focus. 2012;32(3):E4.

    Article  PubMed  Google Scholar 

  97. Helmstaedter C, Kurthen M, Lux S, et al. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol. 2003;54(4):425–32.

    Article  PubMed  Google Scholar 

  98. Sherman EM, Wiebe S, Fay-McClymont TB, et al. Neuropsychological outcomes after epilepsy surgery: systematic review and pooled estimates. Epilepsia. 2011;52(5):857–69.

    Article  PubMed  Google Scholar 

  99. Baxendale S, Thompson P, Harkness W, et al. Predicting memory decline following epilepsy surgery: a multivariate approach. Epilepsia. 2006;47(11):1887–94.

    Article  PubMed  Google Scholar 

  100. Harden CL. The co-morbidity of depression and epilepsy: epidemiology, etiology, and treatment. Neurology. 2002;59(6 Suppl 4):S48–55.

    Article  CAS  PubMed  Google Scholar 

  101. Hermann BP, Trenerry MR, Colligan RC. Learned helplessness, attributional style, and depression in epilepsy. Bozeman Epilepsy Surgery Consortium. Epilepsia. 1996;37(7):680–6.

    Article  CAS  PubMed  Google Scholar 

  102. Layne Moore J, Elliott JO, Lu B, et al. Serious psychological distress among persons with epilepsy based on the 2005 California Health Interview Survey. Epilepsia. 2009;50(5):1077–84.

    Article  CAS  PubMed  Google Scholar 

  103. Vakharia VN, Duncan JS, Witt JA, et al. Getting the best outcomes from epilepsy surgery. Ann Neurol. 2018;83(4):676–90.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Lee HW, Webber WR, Crone N, et al. When is electrical cortical stimulation more likely to produce afterdischarges? Clin Neurophysiol. 2010;121(1):14–20.

    Article  PubMed  Google Scholar 

  105. Wiebe S, Blume WT, Girvin JP, et al. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311–8.

    Article  CAS  PubMed  Google Scholar 

  106. Engel J Jr, McDermott MP, Wiebe S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307(9):922–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Tanriverdi T, Dudley RW, Hasan A, et al. Memory outcome after temporal lobe epilepsy surgery: corticoamygdalohippocampectomy versus selective amygdalohippocampectomy. J Neurosurg. 2010;113(6):1164–75.

    Article  PubMed  Google Scholar 

  108. Kuang Y, Yang T, Gu J, et al. Comparison of therapeutic effects between selective amygdalohippocampectomy and anterior temporal lobectomy for the treatment of temporal lobe epilepsy: a meta-analysis. Br J Neurosurg. 2014;28(3):374–7.

    Article  PubMed  Google Scholar 

  109. Hu WH, Zhang C, Zhang K, et al. Selective amygdalohippocampectomy versus anterior temporal lobectomy in the management of mesial temporal lobe epilepsy: a meta-analysis of comparative studies. J Neurosurg. 2013;119(5):1089–97.

    Article  PubMed  Google Scholar 

  110. Josephson CB, Dykeman J, Fiest KM, et al. Systematic review and meta-analysis of standard vs selective temporal lobe epilepsy surgery. Neurology. 2013;80(18):1669–76.

    Article  PubMed  Google Scholar 

  111. Jobst BC, Cascino GD. Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA. 2015;313(3):285–93.

    Article  PubMed  Google Scholar 

  112. Tellez-Zenteno JF, Hernandez Ronquillo L, Moien-Afshari F, et al. Surgical outcomes in lesional and non-lesional epilepsy: a systematic review and meta-analysis. Epilepsy Res. 2010;89(2–3):310–8.

    Article  PubMed  Google Scholar 

  113. de Tisi J, Bell GS, Peacock JL, et al. The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet. 2011;378(9800):1388–95.

    Article  PubMed  Google Scholar 

  114. Engel J Jr, Van Ness PC, Rasmussen TB, et al. Outcome with respect to epileptic seizures. In: Engel Jr J, editor. Surgical treatment of the epilepsies. New York: Raven Press; 1993. p. 609–21.

    Google Scholar 

  115. Wieser HG, Blume WT, Fish D, et al., ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia. 2001;42(2):282–6.

    Google Scholar 

  116. Graham D, Tisdall MM, Gill D. Corpus callosotomy outcomes in pediatric patients: a systematic review. Epilepsia. 2016;57(7):1053–68.

    Article  PubMed  Google Scholar 

  117. Asadi-Pooya AA, Sharan A, Nei M, et al. Corpus callosotomy. Epilepsy Behav. 2008;13(2):271–8.

    Article  PubMed  Google Scholar 

  118. Asadi-Pooya AA, Malekmohamadi Z, Kamgarpour A, et al. Corpus callosotomy is a valuable therapeutic option for patients with Lennox-Gastaut syndrome and medically refractory seizures. Epilepsy Behav. 2013;29(2):285–8.

    Article  PubMed  Google Scholar 

  119. Tellez-Zenteno JF, Dhar R, Wiebe S. Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis. Brain. 2005;128(Pt 5):1188–98.

    Article  PubMed  Google Scholar 

  120. Jea A, Vachhrajani S, Widjaja E, et al. Corpus callosotomy in children and the disconnection syndromes: a review. Childs Nerv Syst. 2008;24(6):685–92.

    Article  PubMed  Google Scholar 

  121. Krishnaiah B, Ramaratnam S, Ranganathan LN. Subpial transection surgery for epilepsy. Cochrane Database Syst Rev. 2015;(12):Cd008153.

    Google Scholar 

  122. Rasmussen T. Hemispherectomy for seizures revisited. Can J Neurol Sci. 1983;10(2):71–8.

    Article  CAS  PubMed  Google Scholar 

  123. Kim J-s, Park E-K, Shim K-W, et al. Hemispherotomy and functional hemispherectomy: indications and outcomes. J Epilepsy Res. 2018;8(1):1–5.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Hu WH, Zhang C, Zhang K, et al. Hemispheric surgery for refractory epilepsy: a systematic review and meta-analysis with emphasis on seizure predictors and outcomes. J Neurosurg. 2016;124(4):952–61.

    Article  PubMed  Google Scholar 

  125. Shukla ND, Ho AL, Pendharkar AV, et al. Laser interstitial thermal therapy for the treatment of epilepsy: evidence to date. Neuropsychiatr Dis Treat. 2017;13:2469–75.

    Article  PubMed  PubMed Central  Google Scholar 

  126. Kang JY, Wu C, Tracy J, et al. Laser interstitial thermal therapy for medically intractable mesial temporal lobe epilepsy. Epilepsia. 2016;57(2):325–34.

    Article  PubMed  Google Scholar 

  127. Jermakowicz WJ, Kanner AM, Sur S, et al. Laser thermal ablation for mesiotemporal epilepsy: analysis of ablation volumes and trajectories. Epilepsia. 2017;58(5):801–10.

    Article  PubMed  PubMed Central  Google Scholar 

  128. Drane DL, Loring DW, Voets NL, et al. Better object recognition and naming outcome with MRI-guided stereotactic laser amygdalohippocampotomy for temporal lobe epilepsy. Epilepsia. 2015;56(1):101–13.

    Article  PubMed  Google Scholar 

  129. Jermakowicz WJ, Ivan ME, Cajigas I, et al. Visual deficit from laser interstitial thermal therapy for temporal lobe epilepsy: anatomical considerations. Oper Neurosurg (Hagerstown, Md.). 2017;13(5):627–33.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of California, Irvine, CA, USA

    Mona Sazgar

  2. Department of Neurology, Riverside, CA, USA

    Michael G. Young

Authors
  1. Mona Sazgar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael G. Young
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sazgar, M., Young, M.G. (2019). Treatment of Seizures. In: Absolute Epilepsy and EEG Rotation Review. Springer, Cham. https://doi.org/10.1007/978-3-030-03511-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-03511-2_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-03510-5

  • Online ISBN: 978-3-030-03511-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation